COMPANY PROFILE

Aerwave Medical

Explore full profile

Developing a unique alternative to traditional medications used to treat COPD and asthma

New York City, United StatesFounded 2020Health Tech & Medtech

Valuation $25–50M Last recorded · 2025

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Aerwave Medical

AerWave Medical is at the forefront of transforming the treatment of pulmonary diseases such as asthma, Chronic Obstructive Pulmonary Disease (COPD), and other advanced lung conditions through an innovative interventional approach. The company targets patients suffering from these chronic respiratory conditions, providing them with alternatives to traditional medication-based treatments. Operating within the healthcare and medical technology market, AerWave Medical leverages cutting-edge research and development to create minimally invasive procedures that aim to improve patient outcomes and quality of life. The business model revolves around developing and commercializing these medical interventions, generating revenue through the sale of proprietary medical devices and therapies to healthcare providers and institutions. By focusing on unmet medical needs and harnessing a world-class management team, AerWave Medical positions itself as a leader in the pulmonary care sector.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2020
Headquarters: New York City, United States
Open positions: None listed
Dealroom signal: 19.3/100
Industry: Health
Sub-industry: Medical Devices
Sector: Health Tech & Medtech, Surgery, Respiratory, Pulmonary, Hard Tech, DT and LS, science-based
Technology: Deep Tech
Business model: Manufacturing
Links: Website

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Funding history

5 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
EARLY VC✓Equity / VC	Jan 2025	$12M	$48M	Undisclosed	↗
EARLY VCEquity / VC	Aug 2023	$4M	$16M	Undisclosed	—

Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Growth signals

Aerwave Medical website traffic

Latest recorded traffic for Aerwave Medical is 730 monthly website visits, up 7200% over the last three months.

Latest monthly visits730 3-month web change+7200%

Monthly website visitsSep 2023–May 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
NMNoah MedicalNoah Medical's next-generation robotic platform targets early diagnosis and treatment of patients across multiple indications	Redwood City, United States	Operational	312	$150M	$600M
CRCryosaMedical device company developing novel treatments for obstructive sleep apnea	Arden Hills, United States	Operational
AHApreo HealthAirway scaffold implant for severe emphysema treatment	Stockholm, United States	Operational
JTJiashu Medical TechnologySpecialized medical technology for interventional pulmonology solutions	China	Operational
ESEpic Airway SystemsChanging the standard of care for elective and emergent airway management, to save lives, time and money, while reducing medication administration and improving patient and practitioner safety	Schenectady, United States	Operational
HMHollo MedicalPortable valved holding chamber for asthma inhalers	Halifax, Canada	Operational
TETelesairDeveloper of innovative medical technologies enabling healthier living and reducing the burden of care	United States	Operational
ARartiqMedical AI software for respiratory disease diagnostics	Seoul, South Korea	Acquired